PP 13
Acute phase reactants in chronic inflammation leading to secondary myelofibrosis in polycythemia vera and essential thrombocytosis
Lido
2294
Vezesque se leu este artigo
1053
Total PDF
1241
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 15 | 7 | 22 |
| 2025 5 | 49 | 14 | 63 |
| 2025 4 | 37 | 14 | 51 |
| 2025 3 | 61 | 16 | 77 |
| 2025 2 | 33 | 17 | 50 |
| 2025 1 | 38 | 23 | 61 |
| 2024 12 | 29 | 11 | 40 |
| 2024 11 | 46 | 14 | 60 |
| 2024 10 | 25 | 18 | 43 |
| 2024 9 | 34 | 20 | 54 |
| 2024 8 | 32 | 13 | 45 |
| 2024 7 | 20 | 23 | 43 |
| 2024 6 | 27 | 28 | 55 |
| 2024 5 | 24 | 28 | 52 |
| 2024 4 | 20 | 15 | 35 |
| 2024 3 | 20 | 22 | 42 |
| 2024 2 | 23 | 22 | 45 |
| 2024 1 | 21 | 28 | 49 |
| 2023 12 | 24 | 25 | 49 |
| 2023 11 | 38 | 42 | 80 |
| 2023 10 | 24 | 21 | 45 |
| 2023 9 | 24 | 26 | 50 |
| 2023 8 | 16 | 12 | 28 |
| 2023 7 | 21 | 9 | 30 |
| 2023 6 | 36 | 16 | 52 |
| 2023 5 | 24 | 14 | 38 |
| 2023 4 | 23 | 4 | 27 |
| 2023 3 | 15 | 14 | 29 |
| 2023 2 | 19 | 10 | 29 |
| 2023 1 | 15 | 8 | 23 |
| 2022 12 | 26 | 14 | 40 |
| 2022 11 | 18 | 15 | 33 |
| 2022 10 | 20 | 16 | 36 |
| 2022 9 | 21 | 16 | 37 |
| 2022 8 | 17 | 20 | 37 |
| 2022 7 | 20 | 27 | 47 |
| 2022 6 | 13 | 17 | 30 |
| 2022 5 | 13 | 18 | 31 |
| 2022 4 | 16 | 21 | 37 |
| 2022 3 | 9 | 14 | 23 |
| 2022 2 | 15 | 25 | 40 |
| 2021 1 | 10 | 18 | 28 |
| 2021 12 | 9 | 21 | 30 |
| 2021 11 | 13 | 19 | 32 |
| 2021 10 | 18 | 23 | 41 |
| 2021 9 | 15 | 23 | 38 |
| 2021 8 | 24 | 27 | 51 |
| 2021 7 | 17 | 21 | 38 |
| 2021 6 | 17 | 18 | 35 |
| 2021 5 | 24 | 29 | 53 |
| 2021 4 | 23 | 48 | 71 |
| 2021 3 | 16 | 22 | 38 |
| 2021 2 | 12 | 13 | 25 |
| 2020 1 | 9 | 13 | 22 |
| 2020 12 | 5 | 13 | 18 |
| 2020 11 | 8 | 8 | 16 |
Mostrar tudo
